Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Healthcare Medical Devices
Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Diagnos Inc
Bullboard Posts
User Avatar Image
(40)
•••
Post by LannyMcdonaldon May 15, 2018 1:20pm
93 Views
Post# 28033649

Health Technology Assessment Topic

Health Technology Assessment TopicThanks for your email regarding submitting a Health Technology Assessment topic. We have looked into the website functionality issue you mentioned and the website is in good working order. Please try again to submit your suggestion using the online form at this link:
 
https://www.surveygizmo.com/s3/3370223/HTA-Application
 
If you continue to experience problems with the form, please don’t hesitate to reach out to us again.
Best regards,
Claude
 
Claude Soulodre
Project Manager, Corporate Services
Health Quality Ontario

Hey Everyone here is the link to submitting a Health Technology Assessment Topic. I filled one out today. One of you Ney sayers said it may take a year? Well how long will it take if you don’t  fill it out?

Question 6 Name of Technology - CARA - Computer Assisted Retinal Analysis

Question 7 Health condition the technology treats - Diabetic Retinopathy

Good luck with the rest of the form.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities